RecruitingNot applicableNCT07455864

Lysosomal Acid Lipase Deficiency in Risk Groups

Studying Lysosomal acid lipase deficiency

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: AstraZeneca
Principal Investigator: AstraZeneca Clinical Study Information Center
Enrollment: 1200 enrolled
Eligibility: All sexes
Timeline: 2026 – 2028

Study locations (1)

Research site, Nizhny Novgorod, Russia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07455864 on ClinicalTrials.gov

Other trials for Lysosomal acid lipase deficiency

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT01633489
Lysosomal Acid Lipase (LAL) Deficiency Registry
Alexion Pharmaceuticals, Inc.

See all trials for Lysosomal acid lipase deficiency →

← Back to all trials